Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial)
Not Applicable
- Conditions
- COVID-19
- Registration Number
- PACTR202004693933092
- Lead Sponsor
- Misr University for Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Health care workers aged 18-50 years old
Exclusion Criteria
acute severe illness
• recent receipt of a blood product
• history of thrombocytopenia
• Pregnant females
• any chronic medical condition
• Any participant receiving any immune suppressive medication
• Immunocompromised staff
• Participants who have egg allergy
• Participants who care for immune-compromised hosts
• Participants who test positive for COVID-19 serology prior to randomization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serologic evidence of infection
- Secondary Outcome Measures
Name Time Method Incidence of respiratory illness defined as two or more of the following<br> o Fever<br>o Sore throat<br>o Dry cough<br>o Runny nose<br>o Shortness of breath<br>? Participants will be phoned weekly for assessment and reporting any symptoms and if participant complains of any respiratory symptom<br>he will be evaluated clinically and COVID-19 PCR swab will be sent and if they test positive they will be treated as per national protocol and clinical<br>outcome will be reported<br>? Incidence of admission to hospital